Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
3SBio announces 2021 interim results, with strong growth in core businesses and significant progress in clinical development
2021-08-26 22:09
Tigermed Reports 2021 Interim Results with Strong Financial Growth
2021-08-25 20:49
ExoCoBio to Build the World's First Clinical Grade Exosome GMP Manufacturing Facility
2021-08-25 19:44
GenScript Biotech Reports First Half 2021 Results
2021-08-24 21:38
Kintor Pharma to Report 2021 Interim Financial Results and Host Conference Call on August 30, 2021
2021-08-24 17:04
Hepagene Therapeutics, Inc. Announces Positive Results from Phase I Trial of HPG1860
2021-08-23 22:00
PharmAbcine to Participate in H.C. Wainright 23rd Annual Global Investment Conference
2021-08-23 20:00
Roche and KeChow Reach a Cooperation Agreement
2021-08-20 23:00
Neurophth Expands Its Global Gene Therapy Leadership Team with the Appointment of Dr. Zhengbin Li as Head of Commercial
2021-08-19 22:00
Daewoong Pharmaceutical and Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics
2021-08-19 21:00
PharmAbcine Announces Submission of PCT for an Anti-ANG2 Antibody for the Treatment of Ocular Diseases
2021-08-19 20:00
MicroConstants to Join BioAgilytix Family
2021-08-19 02:30
Henlius reports half-year (H1) 2021 results, outlines remarkable growth in commercialization and needs-driven innovation
2021-08-18 21:35
PharmAbcine to Participate in Biotechgate Digital Partnering
2021-08-17 20:00
First Edition of World Conference on Early Detection of Cancer Set to Start in November in Hainan, China
2021-08-16 22:13
Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors
2021-08-16 20:00
Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel Oral Drug for COVID-19
2021-08-16 15:29
GeneQuantum announces a key leadership appointment
2021-08-16 10:00
InxMed's IN10018 Receives U.S. FDA Fast Track Designation for the Treatment of Platinum-resistant Ovarian Cancer
2021-08-16 09:31
Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India
2021-08-16 08:00
1
82
83
84
85
86
203